We speak with leading neurosurgeon and spinal cord injury neuroscientist Dr. Michael Fehlings. Dr Fehlings is Professor of Neurosurgery, Vice-Chair Research, Department of Surgery, Co-Director, Spine Program, McLaughlin Scholar in Molecular Medicine, University of Toronto. He is also the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration, Senior Scientist, Krembil Brain Institute and Scientist, McEwen Centre for Regenerative Medicine Toronto Western Hospital, University Health Network, Canada.
Dr. Fehlings discusses the international Surgical Timing in Acute Spinal Cord Injury Study (STASCIS) seminal study on the optimal timing of surgical decompression for spinal cord injury, improving SCI care, the latest research in spinal cord injury, and how to optimize spinal cord injury care. He also provides updates and perspectives on many current and exciting research approaches in spinal cord injury including stem cells, hypothermia, and neuromodulation. As Principal Investigator, he presents an update on the RISCIS clinical trial of Riluzole, one of the most promising pharmacotherapies for acute spinal cord injury.
Listen to this and other in-depth conversations on your favorite Podcast:
|Dr. Max Boakye, Neurosurgeon, and Neuroscientist, currently Professor of Neurosurgery, Chief of Spinal Neurosurgery, Director of Quality Improvement, and Clinical Director of the Kentucky Spinal Cord Injury Research Center, interviews leading neuroscientists, health administrators, neurosurgeons, educators, neuro and spine health care experts, and patients in his Podcast show: Optimal neuro|spine. His in-depth conversations brings to light topics on:
Dr. Boakye present the most innovative emerging research that will impact neuro|spine care. Join us as we delve one-on-one and have insightful conversations with exciting researchers and experts – voices who have something to teach, enlighten, and inspire us about Optimal neuro|spine.
Maxwell Boakye, MD, MPH
Acting Director, KSCIRC